438 related articles for article (PubMed ID: 21263240)
1. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
2. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
3. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
[No Abstract] [Full Text] [Related]
4. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
Shim HS; Jung WH; Kim H; Park K; Cho NH
APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
[TBL] [Abstract][Full Text] [Related]
5. A case of sebaceoma with extensive apocrine differentiation.
Tanahashi J; Kashima K; Daa T; Kondoh Y; Yada N; Kuratomi E; Yokoyama S
Am J Dermatopathol; 2008 Aug; 30(4):408-11. PubMed ID: 18645320
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases.
Moriya T; Sakamoto K; Sasano H; Kawanaka M; Sonoo H; Manabe T; Ito J
Mod Pathol; 2000 Jan; 13(1):13-8. PubMed ID: 10658905
[TBL] [Abstract][Full Text] [Related]
8. [Apocrine carcinoma of the breast--a morphologic comparison of the apocrine sweat glands and the apocrine metaplastic epithelia in mastopathy].
Tsubura A; Uemura Y; Inui T; Izumi H; Morii S
Gan No Rinsho; 1988 Jun; 34(7):901-7. PubMed ID: 3398262
[TBL] [Abstract][Full Text] [Related]
9. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature.
Miyamoto T; Hagari Y; Inoue S; Watanabe T; Yoshino T
J Clin Pathol; 2005 Jul; 58(7):757-61. PubMed ID: 15976347
[TBL] [Abstract][Full Text] [Related]
10. Apocrine adenoma of the breast.
Cashell AW
W V Med J; 2008; 104(2):16-9. PubMed ID: 18491794
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Study of Immunohistochemical Myoepithelial Cell Markers in Cutaneous Benign Cystic Apocrine Lesions.
Wood A; Houghton SL; Biswas A
Am J Dermatopathol; 2016 Jul; 38(7):475-83. PubMed ID: 26630681
[TBL] [Abstract][Full Text] [Related]
12. Apocrine adenoma of the breast coexistent with invasive carcinoma.
Bezić J; Forempoher G; Poljicanin A; Gunjaca G
Pathol Res Pract; 2007; 203(11):809-12. PubMed ID: 17936522
[TBL] [Abstract][Full Text] [Related]
13. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
14. Apocrine mixed tumor of the skin ("mixed tumor of the folliculosebaceous-apocrine complex"). Spectrum of differentiations and metaplastic changes in the epithelial, myoepithelial, and stromal components based on a histopathologic study of 244 cases.
Kazakov DV; Belousova IE; Bisceglia M; Calonje E; Emberger M; Grayson W; Hantschke M; Kempf W; Kutzner H; Michal M; Spagnolo DV; Virolainen S; Zelger B
J Am Acad Dermatol; 2007 Sep; 57(3):467-83. PubMed ID: 17707152
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic alterations in myoepithelial cells of the breast in normal and pathologic conditions.
Pusztaszeri M
Am J Surg Pathol; 2010 Dec; 34(12):1886; author reply 1886-7. PubMed ID: 21107098
[No Abstract] [Full Text] [Related]
16. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
Parks A; Branch KD; Metcalf J; Underwood P; Young J
Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
[TBL] [Abstract][Full Text] [Related]
17. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
Gottlieb C; Raju U; Greenwald KA
Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
[TBL] [Abstract][Full Text] [Related]
18. Intraductal carcinoma of mammary-type apocrine epithelium arising within a papillary hydradenoma of the vulva. Report of a case and review of the literature.
Pelosi G; Martignoni G; Bonetti F
Arch Pathol Lab Med; 1991 Dec; 115(12):1249-54. PubMed ID: 1662944
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
[TBL] [Abstract][Full Text] [Related]
20. Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy.
Cserni G
APMIS; 2012 Mar; 120(3):249-52. PubMed ID: 22339683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
